Answers are grounded in this paper and cite their sources.
Receptor-interacting protein kinase 1 (RIPK1) dictates the balance between TNF-induced cell survival and death. Among the phosphorylation-dependent checkpoints that restrain RIPK1, threonine 190 (T190) is mechanistically unique: both phospho-deficient and phospho-mimetic mutations abolish kinase activity, indicating that the unmodified residue itself is required for RIPK1 activation. Despite this biochemical insight, the physiological relevance of T190 has remained unexplored due to the absence of an in vivo genetic model. To address this gap, we generated Ripk1 T190A/T190A knock-in mice. We show that the T190A mutation selectively abolishes RIPK1-dependent apoptosis, necroptosis, and pyroptosis, confers strong protection against TNF-induced systemic inflammatory response syndrome (SIRS), and fully rescues the embryonic lethality of Tbk1 −/− mice. Mechanistically, T190A specifically blocks RIPK1 autophosphorylation at Ser166, establishing T190 as a non-redundant licensing checkpoint that fundamentally distinguishes it from conventional inhibitory phosphorylation sites.
No takes yet. Share an insight, caveat, or question.
Luan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: